Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jens Benn Sørensen. (2011) Pharmacokinetic evaluation of pemetrexed. Expert Opinion on Drug Metabolism & Toxicology 7:7, pages 919-928.
Read now
Read now
Agnieszka Korfel & Eckhard Thiel. (1998) Successful Treatment of Non-Hodgkin's Lymphoma of the Central Nervous System with BMPD Chemotherapy Followed by Radiotherapy. Leukemia & Lymphoma 30:5-6, pages 609-617.
Read now
Read now
Articles from other publishers (17)
Katarzyna Rakoczy, Wojciech Szlasa, Natalia Sauer, Jolanta Saczko & Julita Kulbacka. (2022) Molecular relation between biological stress and carcinogenesis. Molecular Biology Reports 49:10, pages 9929-9945.
Crossref
Crossref
Wang Chun Kwok, Tan Fong Cheong, Ka Yan Chiang, James Chung Man Ho, David Chi Leung Lam, Mary Sau Man Ip & Terence Chi Chun Tam. (2021) Haematological toxicity of pemetrexed in patients with metastatic non-squamous non-small cell carcinoma of lung with third-space fluid. Lung Cancer 152, pages 15-20.
Crossref
Crossref
Nicolas J. Dickgreber, Jens Benn Sorensen, Luis G. Paz-Ares, Tine Kjestrup Schytte, Jane E. Latz, Karen B. Schneck, Zheng Yuan & José Miguel Sanchez-Torres. (2010) Pemetrexed Safety and Pharmacokinetics in Patients with Third-Space Fluid. Clinical Cancer Research 16:10, pages 2872-2880.
Crossref
Crossref
Rosalyn A. Juergens, Alex I. Spira & Julie R. Brahmer. 2008. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
925
944
.
T. Yamao, Y. Shimada, K. Shirao, A. Ohtsu, N. Ikeda, I. Hyodo, H. Saito, H. Iwase, Y. Tsuji, T. Tamura, S. Yamamoto & S. Yoshida. (2004) Phase II Study of Sequential Methotrexate and 5-Fluorouracil Chemotherapy Against Peritoneally Disseminated Gastric Cancer with Malignant Ascites: a Report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial. Japanese Journal of Clinical Oncology 34:6, pages 316-322.
Crossref
Crossref
Joel M. Kremer. (2004) Toward a better understanding of methotrexate. Arthritis & Rheumatism 50:5, pages 1370-1382.
Crossref
Crossref
James G. Wright & Alan V. Boddy. (2001) All Half-Lives Are Wrong, But Some Half-Lives Are Useful. Clinical Pharmacokinetics 40:4, pages 237-244.
Crossref
Crossref
Chris H. Takimoto. 2001. Cancer Chemoprevention. Cancer Chemoprevention
85
101
.
Glen Stevens & David M. Peereboom. 2000. Regional Chemotherapy. Regional Chemotherapy
305
317
.
Georg A. Bjarnason, Christine Cripps, Rakesh Goel, Sheldon Fine, Amit M. Oza, Jamey R. Skillings, Ian Kerr, Colin J. Germond, Malcolm J. Moore, Jean A. Maroun, Edmee Franssen & Helene Dulude. (1998) Phase I-II Study of 5-Fluorouracil, Leucovorin, Doxorubicin, Methotrexate, and Long-Term Oral Etoposide (FLAME) in Unresectable or Metastatic Gastric Cancer. American Journal of Clinical Oncology 21:6, pages 537-542.
Crossref
Crossref
Stanley L. Marks, P.Richard Vulliet, Philip H. Kass & Quinton R. Rogers. (1997) Dietary composition alters methotrexate toxicity without changing its pharmacokinetic parameters in cats. The Journal of Nutritional Biochemistry 8:2, pages 79-84.
Crossref
Crossref
F. von Bruchhausen, S. Ebel, E. Hackenthal, G. Dannhardt, A. W. Frahm, U. Holzgrabe, K. Keller, E. Nürnberg, H. Rimpler, G. Schneider, P. Surmann, H. U. Wolf & G. Wurm. 1993. Hagers Handbuch der Pharmazeutischen Praxis. Hagers Handbuch der Pharmazeutischen Praxis
787
1056
.
Jørn Herrtedt, Paul Clementsen & Ole Paaske Hansen. (1992) Increased myelosuppression during cytostatic treatment and pleural effusion in patients with small cell lung cancer. European Journal of Cancer 28:6-7, pages 1070-1073.
Crossref
Crossref
Rebecca S. Finley & Cynthia Lynn LaCivita. 1992. Applied Therapeutics. Applied Therapeutics
945
992
.
G. Deray, D. Khayat, P. Cacoub, R. Bourbouze, L. Musset, A. Baumelou, C. Jacquillat & C. Jacobs. (1989) The effects of diltiazem on methotrexate-induced nephrotoxicity. European Journal of Clinical Pharmacology 37:4, pages 337-340.
Crossref
Crossref
Ross C. Donehower, Neil B. Rosenshein, Jacob Rotmensch & David S. Ettinger. (1987) Sequential methotrexate and 5-Fluorouracil in advanced ovarian carcinoma. Gynecologic Oncology 27:1, pages 90-96.
Crossref
Crossref
John S. Spratt, Michael Edwards, T. Kubota, R. Lindberg & Michael T. Tseng. (1986) Peritoneal carcinomatosis: Anatomy, physiology, diagnosis, management. Current Problems in Cancer 10:11, pages 553-584.
Crossref
Crossref